1 / 3
google
Article details
- Package size
- 56
- Selling units
- 56
- Measure
- Kapsel(n)
- Galenic form
- Kapseln
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
80.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
12.2317 MG | Substance | HNIDK |
Authorization holder
Schwabe Pharma AG
6403 Küssnacht am Rigi
Authorization information
- Swissmedic authorization number
- 63019
- Drug name
- Lasea, Kapseln
- Galenic form
- KAPWE
- ATC Code
- N05BX05
- Authorization status
- Z
- Dispensing category
- D
- First authorization
- 20/05/2016
- Authorization expiration date
- 31/12/9999
- IT Number
- 01.04.1.
- Domain
- Human medicine
Package details
- Description (FR)
- LASEA caps moll 80 mg 56 pce
- Description (DE)
- LASEA Weichkaps 80 mg 56 Stk
- Market launch
- 20/05/2016
- Narcotic (BTM)
- No
Other package sizes (1)
LASEA caps moll 80 mg 28 pce
28 KAP
GTIN: 7680630190017